Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24667544.
- Also identified by DOI 10.1038/ncomms4543 and PMC identifier 3974217.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A fundamental goal in cancer biology is to identify the cells and signalling pathways that are keys to induce tumour regression. Here we use a spontaneously self-regressing tumour, cutaneous keratoacanthoma (KAs), to identify physiological mechanisms that drive tumour regression. By using a mouse model system that recapitulates the behaviour of human KAs, we show that self-regressing tumours shift their balance to a differentiation programme during regression. Furthermore, we demonstrate that developmental programs utilized for skin hair follicle regeneration, such as Wnt, are hijacked to sustain tumour growth and that the retinoic acid (RA) signalling pathway promotes tumour regression by inhibiting Wnt signalling. Finally, we find that RA signalling can induce regression of malignant tumours that do not normally spontaneously regress, such as squamous cell carcinomas. These findings provide new insights into the physiological mechanisms of tumour regression and suggest therapeutic strategies to induce tumour regression.
Medical subject headings
- Carcinoma, Squamous Cell
- Hair Follicle
- Keratoacanthoma
- Skin Neoplasms
- Stem Cells
- Tretinoin
- Wnt Signaling Pathway